A

Amgen

Makes biotech medicines for serious illnesses

Medical Value & Access Liaison - National & Strategic Accounts

Biology & BiotechPosted on Nov 14
Full-timeUnited States$157.8k - $213.5k /yr

About the Job

Requirements

  • A doctorate degree and 2 years of Medical Affairs experience, or a master's degree and 6 years of Medical Affairs experience, or a bachelor's degree and 8 years of Medical Affairs experience.
  • Deep knowledge of managed markets, the U.S. reimbursement landscape, pharmacoeconomics, population health, and broad healthcare trends.
  • Strong advocacy, communication, and team cohesion skills.
  • Critical thinking, analytical, and project management skills.
  • Ability to lead and manage projects from concept to completion.
  • Strong interpersonal, negotiation, active listening, and relationship management skills.
  • Ability to interface effectively with all levels, including senior management.
  • Ability to influence others while fostering a value-based environment of dedication and fairness.
  • Ability to understand, plan, and navigate in a matrix and at times ambiguous environment.
  • Strong verbal and written communication skills, including the ability to clearly and effectively present clinical and pharmacoeconomic information.
  • Creativity and foresight in anticipating and solving complex business issues.

Responsibilities

  • Represent Amgen to designated national and strategic payer accounts, providing payer and formulary support through value and medical presentations focused on therapeutic and economic outcomes and product utilization, and participating in clinical policy discussions on evidence-based medicine, clinical guidelines, and prior authorization in areas of therapeutic expertise.
  • Identify, develop, and maintain collaborative relationships with current and future payer, employer, policy, and health economics and outcomes research opinion leaders to support Amgen's product portfolio across therapeutic areas.
  • Interact with internal stakeholders to provide feedback on customer trends in interpreting and using value evidence, reimbursement, and payer policy.
  • Lead national-to-regional medical and commercial alignment efforts to support consistent communication of clinical and economic evidence, address payer access challenges, and facilitate pull-through.
  • Provide complex value-based technical information, including medical education, health outcomes, pharmacoeconomics information and models, and research protocol opportunities to appropriate audiences.
  • Serve as the payer-focused clinical subject matter expert for designated products, leading the development and execution of medical value and access strategies, resources, and initiatives with cross-functional stakeholders.
  • Represent Amgen to designated U.S. payer thought leaders in health economics and outcomes research for Amgen Health Economics and Outcomes Research and the Amgen Center for Observational Research.
  • Lead customer partnerships related to population health and real-world evidence generation initiatives.
  • Foster scientific information exchange between the medical community and Amgen relating to reimbursement and coverage policy.
  • Collect and report competitive intelligence within Amgen's competitive intelligence guidelines.
  • Manage internal relationships, budgets, and travel and entertainment within guidelines.
  • Conduct assigned duties within Amgen compliance guidelines.

Desired Qualifications

  • Pharm.D., Ph.D., M.D., or D.O.
  • Five years of biotechnology industry experience working directly with U.S. payer accounts.
  • Expertise in cardiovascular, metabolic, inflammation, bone, oncology, or rare disease therapeutic areas.
  • Experience in patient access in U.S. and/or global markets.
  • Project management experience within a biopharmaceutical company.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs